Does FOSCARNET Cause Interstitial lung disease? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Interstitial lung disease have been filed in association with FOSCARNET (Foscarnet Sodium). This represents 1.0% of all adverse event reports for FOSCARNET.
21
Reports of Interstitial lung disease with FOSCARNET
1.0%
of all FOSCARNET reports
13
Deaths
13
Hospitalizations
How Dangerous Is Interstitial lung disease From FOSCARNET?
Of the 21 reports, 13 (61.9%) resulted in death, 13 (61.9%) required hospitalization, and 8 (38.1%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSCARNET. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does FOSCARNET Cause?
Off label use (610)
Drug ineffective (368)
Drug resistance (309)
Acute kidney injury (246)
Cytomegalovirus infection (200)
Nephropathy toxic (198)
Pathogen resistance (190)
Renal impairment (184)
Pancytopenia (170)
Cytomegalovirus infection reactivation (167)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which FOSCARNET Alternatives Have Lower Interstitial lung disease Risk?
FOSCARNET vs FOSFOMYCIN
FOSCARNET vs FOSFOMYCIN TROMETHAMINE
FOSCARNET vs FOSINOPRIL
FOSCARNET vs FOSPHENYTOIN
FOSCARNET vs FOSTAMATINIB